<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00423540</url>
  </required_header>
  <id_info>
    <org_study_id>H06-03345</org_study_id>
    <secondary_id>Health Canada #9427-R1243-21C</secondary_id>
    <nct_id>NCT00423540</nct_id>
  </id_info>
  <brief_title>Exploring the Role of Magnesium in Rest Cramps</brief_title>
  <official_title>Magnesium Status &amp; Effect of Magnesium Infusions on Rest Cramps</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vancouver Coastal Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study sets out to show whether infusions of magnesium can lessen the frequency of rest
      cramps and to determine whether rest cramp sufferers have a deficiency in magnesium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be randomized to receive 5 days of 4 hour IV infusions of D5W either with or
      without 20 mmol magnesium sulfate added. Twenty four hour urinary excretion of magnesium will
      be determined on the first day of infusions to assess whether magnesium deficiency is
      present. Ten normal controls will also undergo a single infusion and collection of urine to
      serve as a comparison group for the urinary excretion data.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the frequency of leg cramps per week (active versus placebo) over the first 30 days post infusions compared to the 30 days prior to randomization (as recorded in patient diaries).</measure>
    <time_frame>See above</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of magnesium status at trial entry as determined by 24 hour fractional excretion of magnesium on day 1 of infusions.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective assessment as to whether cramps were unchanged, more, or less frequent /painful/&quot;bothersome&quot; over the 3 months. following infusions.</measure>
    <time_frame>See above</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall quality of life changes as measured by an SF36 questionnaire.</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Rest Cramps</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous Infusion of Magnesium Sulfate</intervention_name>
    <description>See Detailed Description.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  â‰¥2 leg or foot cramps per week in a 4 week run-in diary

        Exclusion Criteria:

          -  eGFR&lt;50

          -  Neurologic disease

          -  Pregnancy

          -  Heart block

          -  Bradyarhythmia without pacemaker

          -  Digoxin use

          -  Liver disease

          -  Addison's disease

          -  History of MI

          -  CHF

          -  Absence of detectable reflexes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Garrison Scott, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Richmond Hospital</name>
      <address>
        <city>Richmond</city>
        <state>British Columbia</state>
        <zip>V7C 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2007</study_first_submitted>
  <study_first_submitted_qc>January 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2007</study_first_posted>
  <last_update_submitted>December 9, 2008</last_update_submitted>
  <last_update_submitted_qc>December 9, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Scott Garrison</name_title>
    <organization>University of British Columbia</organization>
  </responsible_party>
  <keyword>magnesium infusion</keyword>
  <keyword>magnesium sulfate</keyword>
  <keyword>rest cramps</keyword>
  <keyword>nocturnal leg cramps</keyword>
  <keyword>muscle cramps</keyword>
  <keyword>fractional urinary excretion</keyword>
  <keyword>urinary excretion</keyword>
  <keyword>24 hour urine</keyword>
  <keyword>serum magnesium</keyword>
  <keyword>magnesium deficiency</keyword>
  <keyword>family practice</keyword>
  <keyword>general practice</keyword>
  <keyword>richmond</keyword>
  <keyword>cramp frequency</keyword>
  <keyword>magnesium status</keyword>
  <keyword>urinary magnesium</keyword>
  <keyword>cramp diary</keyword>
  <keyword>sf 36</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Cramp</mesh_term>
    <mesh_term>Spasm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

